关键词：PVA；阴道萎缩；变薄；干燥；发炎；HRT激素；雌激素乳膏剂；局部制剂
摘 要：PVA, also known as vaginal atrophy, is a condition of thinning, drying, and inflammation of the vaginal walls because of less production of estrogen. It occurs most often after menopause. Up to 40 percent of postmenopausal women have symptoms of atrophic vaginitis. Redness, burning, itching, dryness, irritation, and dyspareunia are some of the common symptoms of PVA. HRT, estrogen creams, and other topical preparations are used in the treatment of PVA.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

Product Offerings

Product Profiles

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 PVA Drugs Market in the US

Market Size and Forecast

06.4 PVA Drugs Market in Europe

Market Size and Forecast

06.5 Five Forces Analysis

07. Competitive Analysis of Marketed

Products

08. Pipeline Snapshot

09. Rate of Incidence and Prevalence

10. Market Segmentation by Type

10.1 Topical Estrogen

Vaginal Cream

Vaginal Tablet

Vaginal Ring

10.2 Systemic Estrogen

Oral Estradiol

11. Geographical Segmentation

12. Buying Criteria

13. Market Growth Drivers

14. Drivers and their Impact

15. Market Challenges

16. Impact of Drivers and Challenges

17. Market Trends

18. Trends and their Impact

19. Vendor Landscape

19.1 Competitive Scenario

Key News

Mergers and Acquisitions

19.2 Vendor Analysis 2013

19.3 Other Prominent Vendors

20. Key Vendor Analysis

20.1 Actavis plc

Business Overview

Business Segmentation

Key Information

SWOT Analysis

20.2 Novo Nordisk A/S

Business Overview

Business Segmentation

Key Information

SWOT Analysis

20.3 Pfizer Inc.

Business Overview

Business Segmentation

Key Information

SWOT Analysis

20.4 Shionogi & Co. Ltd.

Business Overview

Key Information

SWOT Analysis

21. Other Reports in this Series